Intratumoral vidutolimod as monot…om a phase 1b study.
🔬 Peer-reviewed
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study.
Milhem MM, Zakharia Y, Davar D, Buchbinder EI, Medina T et al.
Cancer · 2025
Findings
PubMed study on Polysorbate 20 in cosmetics/dermatology
Design
Clinical Trial (Phase I)
Evidence
Moderate
Journal
Cancer
Ingredients studied